The landscape of cancer treatment is constantly evolving, with a growing spotlight on identifying novel therapeutic targets for drug synthesis. Traditional therapies often strike rapidly dividing cells, leading to significant side outcomes. However, the emergence of sophisticated genomic profiling techniques has revolutionized our understanding of